Current Situation of the EU Medical Consumables Market and Export Challenges

In 2026,the demand for disposable medical consumables in the European medical market continues to maintain strong growth,especially for high-quality syringes,medical gloves,high-end dressings and other products.However,behind the market opportunities is an increasingly strict regulatory environment.With the full end of the transition period of the EU Medical Device Regulation (MDR),customs authorities of EU countries have intensified the inspection of imported medical consumables to an unprecedented level.For many domestic factories with production capacity but lack of overseas compliance experience,the complexity of the export process is becoming the biggest bottleneck restricting their expansion into the European market.

Ms.Kang,Sales Director of a medical consumables manufacturer based in Jiangsu,recently encountered such a problem.Although the company’s product quality has passed the ISO 13485 quality management system certification,when trying to export a batch of medical examination gloves to Germany,due to insufficient understanding of the EU’s latest compliance document requirements,the goods were detained by customs at the Port of Hamburg,which not only incurred high port detention fees,but also faced the risk of return.This kind of situation is not rare in the foreign trade industry in 2026,which highlights the core value of professional foreign trade agency services in handling the export of highly regulated products.

Core Value of Zhongshen’s Agency Services

In view of the particularity of medical consumables export to the EU,Zhongshen provides not only simple logistics transportation,but a set of systematic solutions that deeply integrate regulatory compliance and risk control.We are well aware that medical consumables are different from ordinary general merchandise,and any minor flaw in documents may lead to the failure of customs clearance of goods in the destination country.With more than 20 years of experience in the industry,Zhongshen has built a set of export risk control models specifically for medical devices and consumables.We can intervene at the production stage of goods,assist enterprises in sorting out the access requirements of the destination country,and ensure that products have "customs clearance genes" before leaving the country.This pre-compliance management fundamentally solves the risk of goods detention faced by Ms.Kang,and converts the uncertainty of customs clearance into a controllable process.

Document Compliance and Access Barrier Response

In the export process of medical consumables,document preparation is the first barrier,and also the link with the highest risk.The EU market has extremely strict definitions of the legal identity of products,and any omission or error may lead to serious consequences.

• CertificateofFreeSale(CFS)andDeclarationofConformity(DoC):Thesearethe"passes"toentertheEUmarket.ZhongshenwillguideenterprisestoaccuratelyobtaintheCertificateofFreeSaleissuedbythedrugregulatoryauthority,andensurethattheproductinformationintheDeclarationofConformityiscompletelyconsistentwiththephysicalgoodsandtechnicaldocuments.
• CEmarkingtechnicaldocuments:Althoughtheyaretheresponsibilityoftheenterprise,whenreviewingcustomsdeclarationdocuments,theagencyservicewillcross-checkthevalidityoftheCEcertificateandtheproductclassificationcodetoensurethattherearenologicalerrorsinthedeclarationelements.
• CertificateofOriginandmedicaldevicefiling:InresponsetothepreferentialtariffrequirementsforspecificoriginsofsomeEUmemberstates,wewillassistenterprisesinhandlingthecorrespondingCertificateofOrigin,andconfirmwhethertheproducthascompletedthemedicaldeviceregistrationandfilingintheexportdestinationcountry.

Zhongshen’s operation team will conduct a triple review of all the above documents.First,the document specialist will check the basic information,then the customs affairs supervisor will conduct a compliance logic review,and finally the risk control department will conduct the final review.This strict review mechanism can ensure that more than 90% of document hidden dangers are eliminated before the customs declaration data is sent.

Customs Declaration and Inspection and Customs Clearance Time Optimization

In the international trade environment of 2026,the customs inspection rate shows a fluctuating upward trend.As legally inspected products,the customs declaration process for medical consumables is more complex than that of ordinary goods.In this link,Zhongshen has greatly improved customs clearance efficiency through the real-time connection between the digital customs declaration system and the customs database.

In actual operation,we have encountered many inspection cases caused by inaccurate HS code classification.For example,a certain type of medical catheter with special coating may face the risk of return if classified as an ordinary catheter; but if classified as a high value-added product,a detailed composition description is required.Zhongshen’s professional team will provide enterprises with the most accurate HS code pre-classification service based on the composition,use and working principle of the product,combined with the Import and Export Tariff Schedule and the latest classification rulings of the General Administration of Customs.This not only avoids the compliance risk of false declaration,but also ensures that enterprises enjoy the correct export tax rebate policy.

In addition,in response to the EU customs’ high attention to the biosafety of medical products,we have also formulated special standards for packaging and transportation links.We will remind customers that biohazard labels and handling instructions that meet EU standards must be affixed to the packaging,and ensure that the temperature control records during transportation meet the requirements of GSP (Good Supply Practice),so that the required logistics process documents can be smoothly provided during customs clearance in the destination country.

Risk Comparison between Self-export and Agency Export

To more intuitively demonstrate the advantages of agency services,we have compared the performance of enterprises’ self-operation and entrusting Zhongshen as agent on key risk points:

Foreign Exchange Receipt and Payment and Export Tax Rebate Acceleration

Capital turnover efficiency is the lifeline of foreign trade enterprises.Medical consumables export often features large single transaction amounts and high order frequency.In the foreign exchange receipt and payment link,Zhongshen leverages its cooperative advantages with a number of international banks to provide customers with flexible foreign exchange settlement and purchase schemes.In 2026,the international exchange rate market is increasingly volatile,and we can provide exchange rate risk avoidance suggestions based on customers’ shipping plans to help customers lock in profits.

In terms of export tax rebate,speed is profit.The traditional tax rebate process is often extended to several months due to delayed invoice certification or doubts about declaration data.Zhongshen has realized the full-process electronization from customs declaration data collection to tax rebate application through the "paperless" tax rebate declaration system.We will start the invoice collection and verification work immediately after the export declaration of goods is completed,to ensure that the submission is made as early as possible within the declaration period required by the tax authority.For Class A enterprise customers with good reputation,we can also assist in applying for green channel services,reducing the tax rebate cycle to an extremely short level.For Ms.Kang’s company,this means that the funds that originally needed to be tied up for 3-6 months can be quickly returned,greatly easing the capital pressure for raw material procurement.

Choose Customized Agency Services

Medical consumables export is a systematic project,which requires operators not only to understand foreign trade,but also to understand products,regulations and markets.Facing the more complex international trade environment in 2026,the risk cost for enterprises operating alone is rising sharply.By integrating core links such as customs declaration,logistics,foreign exchange and tax rebate,Zhongshen creates tailored export solutions for each customer.Whether it is an emerging enterprise trying to export to the EU for the first time,or a senior manufacturer looking to optimize existing processes and reduce operating costs,Zhongshen can become its most reliable foreign trade partner.We suggest that enterprises connect with a professional agency team as early as possible according to the characteristics of their own products and the specific requirements of the target market,to jointly develop the most efficient and compliant export strategy.